Facebook Pixel Code

Aurobindo Pharma Share Price

NSE
BSE
FUT
OPT

AUROBINDO PHARMA

Sector : Pharmaceuticals and health care | Largecap | BSE

Here's the live share price of Aurobindo Pharma along with daily highs, lows, percentage changes and volume trends, and, all financial information.

₹1,213.80 Closed
1.75₹ 20.90
As on Jan 2, 2026, 4:01 PM IST
Intraday
1W
1M
3M
6M
YTD
1Y
3Y
5Y
10Y

Aurobindo Pharma Price Performance

Today's LowToday's High
₹1,192.80₹1,216.70
₹1,213.80
52 Weeks' Low52 Weeks' High
₹994.35₹1,364.95
₹1,213.80
Open Price
₹1,212.55
Prev. Close
₹1,192.90
Volume
17,091

Over the last 5 years, the share price of Aurobindo Pharma has gained 4.66% CAGR. Over the past year, the corresponding return has been -10.00%.

Aurobindo Pharma’s current P/E of 20.60x helps give context to how the market is valuing the stock based on recent earnings and growth expectations.

Aurobindo Pharma Peer Comparision

Stock Performance
Ratio Performance
Name
1W(%)
1M(%)
3M(%)
6M(%)
1Y(%)
3Y(%)
5Y(%)
Aurobindo Pharma
0.650.4710.995.04-8.0040.824.66
Sun Pharmaceutical Industries
0.65-4.185.893.07-6.4220.1723.42
Divi's Laboratories
-0.78-1.268.63-7.195.4123.6210.53
Torrent Pharmaceuticals
1.624.2110.2616.1413.9635.7522.63
Cipla
0.440.24-0.260.210.1012.1812.68
Dr. Reddy's Laboratories
-1.07-1.960.59-2.92-7.1913.993.56
Lupin
-0.231.326.907.79-10.9742.2215.47
Zydus Lifesciences
0.60-2.02-7.26-8.24-6.0029.7813.53
Mankind Pharma
0.48-0.16-10.07-6.81-25.0415.659.11
Alkem Laboratories
0.80-1.272.6715.751.4422.9913.46
Laurus Labs
2.128.7927.8446.1281.3543.6925.27
Abbott India
-2.71-2.79-6.19-20.83-4.709.4512.37
Glenmark Pharmaceuticals
3.045.354.6616.1626.5969.2532.12
Biocon
-0.51-4.1211.695.036.4914.29-3.41
GlaxoSmithKline Pharmaceuticals
0.82-1.40-9.14-24.6610.9023.579.23
Anthem Biosciences
0.02-1.31-13.85-10.44-10.44-3.61-2.18
Ajanta Pharma
9.5412.7122.2311.682.2834.5521.72
Ipca Laboratories
-2.73-3.086.71-1.09-19.1818.755.32
J B Chemicals & Pharmaceuticals
1.514.5010.6112.51-1.1723.2228.91
Gland Pharma
3.60-3.22-12.28-8.60-9.912.79-6.89

Over the last one year, Aurobindo Pharma has declined 8.00% compared to peers like Sun Pharmaceutical Industries (-6.42%), Divi's Laboratories (5.41%), Torrent Pharmaceuticals (13.96%). From a 5 year perspective, Aurobindo Pharma has underperformed peers relative to Sun Pharmaceutical Industries (23.42%) and Divi's Laboratories (10.53%).

Aurobindo Pharma Financials

Consolidated
Standalone
Quarterly P&L
Annual P&L
Balance Sheet
Cash Flow
Income Statement
Ratios

Aurobindo Pharma Stock Technicals

Moving Average

DaySMAEMA
51,194.991,200.58
101,205.931,200.46
201,195.981,199.34
501,184.851,181.96
1001,132.171,161.34
2001,143.311,159.66

Aurobindo Pharma Share Holding Pattern

In the latest quarter, Aurobindo Pharma remained same as its previous close in promoter holding, while DII stake increased to 27.60%, FII holding fell to 14.21%, and public shareholding moved down to 6.37% compared to the previous quarter — reflecting a shift in investor sentiment across categories.

Aurobindo Pharma Stock Mutual Fund Holdings

Fund Name
No. Of Shares
% of AUM
Amount Invested(in ₹ crore)
1,33,44,7451.781,637
65,00,0002.15797.36
59,69,0008.77732.22
51,74,2775.07634.73
47,00,1251.7576.56
42,94,4835.98526.8
32,30,5880.66396.3
31,80,5056.04390.15
30,30,6115.41371.77
27,22,3120.31333.95

* Excluding Index & Arbitrage Funds

View All Mutual Funds

Aurobindo Pharma Futures

Price
  (%)
As on Invalid Date IST
Open Interest
  (%)
High
Low
Open
Close
Contract Traded
Turnover (in lakhs)

Aurobindo Pharma Options

Price
  (%)
Not traded today
Open Interest
  (%)
High
Low
Open
Close
Contract Traded
Turnover (in lakhs)

Aurobindo Pharma Corporate Actions

Date Time
Announcement
Jan 01, 2026, 11:35 PM ISTAurobindo Pharma - Announcement under Regulation 30 (LODR)-Acquisition
Dec 30, 2025, 4:46 PM ISTAurobindo Pharma - Announcement under Regulation 30 (LODR)-Updates on Acquisition
Dec 27, 2025, 5:24 PM ISTAurobindo Pharma - Curateq Biologics Private Limited, A Wholly Owned Subsidiary Of The Company Has Mutually Agreed To Termina
Dec 23, 2025, 6:59 PM ISTAurobindo Pharma - Announcement under Regulation 30 (LODR)-Acquisition
Dec 18, 2025, 3:36 PM ISTAurobindo Pharma - Completion Of US FDA Inspection At Unit-IV Of APL Healthcare Limited, A Wholly Owned Subsidiary Of The Com

About Aurobindo Pharma

Aurobindo Pharma Ltd. is a Public Limited Listed company incorporated on 26/12/1986 and has its registered office in the State of Telangana, India. Company's Corporate Identification Number(CIN) is L24239TG1986PLC015190 and registration number is 015190. Currently Company is involved in the business activities of Manufacture of other pharmaceutical and botanical products like hina powder etc.. Company's Total Operating Revenue is Rs. 10933.30 Cr. and Equity Capital is Rs. 58.08 Cr. for the Year ended 31/03/2025.

Management

  • Mr. M Ramasubramanian Kumar
    Non Exe.Chairman&Ind.Director
  • Mr. K Nithyananda Reddy
    Vice Chairman & Mng.Director
  • Mr. M Madan Mohan Reddy
    Whole Time Director
  • Mr. P V Ramprasad Reddy
    Non Executive Director
  • Dr. Satakarni Makkapati
    Non Executive Director
  • Mr. P Sarath Chandra Reddy
    Non Executive Director
  • Mr. Girish P Vanvari
    Independent Director
  • Mr. Santanu Mukherjee
    Independent Director
  • Dr. Deepali Pant Joshi
    Independent Director

FAQs on Aurobindo Pharma Share Price

What is the share price of Aurobindo Pharma?

The share price of any company is dynamic and keeps changing depending on the trade initiated. The shares have a fixed opening rate and closing rate. The share price for Aurobindo Pharma is ₹1,213.80 as on Jan 02, 2026.

What kind of stock is Aurobindo Pharma?

The Aurobindo Pharma is operating in the Pharmaceuticals and health care Sector. It is classified as a Largecap stock on the BSE.

What is the Market Cap of Aurobindo Pharma?

The market cap of Aurobindo Pharma is ₹70,497.70 Cr as on Jan 02, 2026.

What are today's High and Low prices of Aurobindo Pharma?

Today’s highest and lowest price of Aurobindo Pharma are ₹1,216.70 and ₹1,192.80.

What are the 52 Week High and 52 Week Low of Aurobindo Pharma?

The 52-week high/low is the highest and lowest price at which Aurobindo Pharma stock has traded in the past 52-week or nearly a year. The 52-week high of Aurobindo Pharma is ₹1,364.95 and 52-week low of Aurobindo Pharma is ₹994.35 as on Jan 02, 2026.

How has the Aurobindo Pharma performed historically in terms of returns?

The Aurobindo Pharma has shown returns of 1.75% over the past day, -0.22% for the past month, 10.99% over 3 months, -10.0% over 1 year, 40.82% across 3 years, and 4.66% over 5 years.

What are the P/E ratio, dividend yield and PB ratio of Aurobindo Pharma?

P/E ratio of and PB ratio of Aurobindo Pharma are 20.60 and 2.01 on Jan 02, 2026. While the company gives a dividend yield of 0.00 per annum.

Aurobindo Pharma News

icon
Market Pulse